ScholarIQanswers from OpenAlex
T-cell agonists in cancer immunotherapy
PaperCitations, authors & open-access status
T-cell agonists in cancer immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does T-cell agonists in cancer immunotherapy have?
ScholarIQcitation count
T-cell agonists in cancer immunotherapy has 121 citations in the OpenAlex counts ScholarIQ stores.
When was T-cell agonists in cancer immunotherapy published?
ScholarIQyear
T-cell agonists in cancer immunotherapy has 2020 year in the ScholarIQ index.
What is the open-access status of T-cell agonists in cancer immunotherapy?
ScholarIQoa status
T-cell agonists in cancer immunotherapy has gold oa status in the ScholarIQ index.
What is the DOI of T-cell agonists in cancer immunotherapy?
ScholarIQdoi
The DOI for T-cell agonists in cancer immunotherapy is on the source record.
What is the PMID of T-cell agonists in cancer immunotherapy?
ScholarIQpmid
The PMID for T-cell agonists in cancer immunotherapy is on the source record.
What is the OpenAlex record for T-cell agonists in cancer immunotherapy?
ScholarIQopenalex
The OpenAlex for T-cell agonists in cancer immunotherapy is on the source record.